BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 351383)

  • 1. Screening of safrole, eugenol, their ninhydrin positive metabolites and selected secondary amines for potential mutagenicity.
    Green NR; Savage JR
    Mutat Res; 1978 May; 57(2):115-21. PubMed ID: 351383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
    Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
    Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutagenicity of the metabolites of the epoxide-diol pathway of safrole and its analogs. Study on Salmonella typhimurium].
    Dorange JL; Delaforge M; Janiaud P; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(5):1041-8. PubMed ID: 146546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity testing of benomyl, methyl-2-benzimidazole carbamate, streptozotocin and N-methyl-N'-nitro-N-nitrosoguanidine in Salmonella typhimurium in vitro and in rodent host-mediated assays.
    Ficsor G; Bordas S; Stewart SJ
    Mutat Res; 1978 Aug; 51(2):151-64. PubMed ID: 151228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity of safrole-related chemicals in microbial test systems.
    Sekizawa J; Shibamoto T
    Mutat Res; 1982 Apr; 101(2):127-40. PubMed ID: 6808388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safrole, eugenol and methyleugenol induce intrachromosomal recombination in yeast.
    Schiestl RH; Chan WS; Gietz RD; Mehta RD; Hastings PJ
    Mutat Res; 1989 Dec; 224(4):427-36. PubMed ID: 2685589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of trans-anethole, estragole, eugenol, and safrole in the Ames Salmonella typhimurium assay.
    To LP; Hunt TP; Andersen ME
    Bull Environ Contam Toxicol; 1982 Jun; 28(6):647-54. PubMed ID: 7049270
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites.
    Wislocki PG; Miller EC; Miller JA; McCoy EC; Rosenkranz HS
    Cancer Res; 1977 Jun; 37(6):1883-91. PubMed ID: 192464
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenicity studies with nitrofurans. II. mutagenicity of nitrofurylacrylic acid for Salmonella typhimurium.
    Cerná M; Srám RJ
    Mutat Res; 1980 Jan; 77(1):1-12. PubMed ID: 6987507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
    Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
    Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG; Paes DJ
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressed mutagenicity of benzo[a]pyrene by the liver S9 fraction and microsomes from eugenol-treated rats.
    Yokota H; Hoshino J; Yuasa A
    Mutat Res; 1986 Dec; 172(3):231-6. PubMed ID: 3537779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the mutagenicity of anesthetics and their metabolites.
    Waskell L
    Mutat Res; 1978 May; 57(2):141-53. PubMed ID: 351387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of N-nitrosopiperazine derivatives in Salmonella typhimurium.
    Rao TK; Young JA; Lijinsky W; Epler JL
    Mutat Res; 1978 May; 57(2):127-34. PubMed ID: 351385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine.
    Guttenplan JB
    Carcinogenesis; 1993 May; 14(5):1013-9. PubMed ID: 8504462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of 2,6-dinitrotoluene and its metabolites, and their related compounds in Salmonella typhimurium.
    Sayama M; Mori M; Shirokawa T; Inoue M; Miyahara T; Kozuka H
    Mutat Res; 1989 Jul; 226(3):181-4. PubMed ID: 2664501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxic effects of eugenol, isoeugenol and safrole in the wing spot test of Drosophila melanogaster.
    Munerato MC; Sinigaglia M; Reguly ML; de Andrade HH
    Mutat Res; 2005 Apr; 582(1-2):87-94. PubMed ID: 15781214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.